Nasdaq

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

Authorized for use in the U.S. in January 2021, Ortho's VITROS® SARS-CoV-2 Antigen Test offers reliable detection of SARS-CoV-2 in patients suspected of COVID-19 by their healthcare provider within ...
WBAL-TV

Coronavirus testing volume drops significantly in Maryland

EARLY ON IN THE PANDEMIC THE STATE’S VEHICLE EMISSION STATIONS. WHERE USED IS CORONAVIRUS TESTING SITE PART OF A STRATEGY TO RAMP UP TESTING TO TRY TO CONTAIN THE VIRUS HAS SPREAD. BUT THE EMISSION ...
KRON4 News

San Francisco to open high-volume COVID-19 testing site as cases rise

SAN FRANCISCO (BCN) – After scaling back on its high volume COVID-19 testing sites earlier this year, San Francisco city officials said on Monday they will once again open a large testing site as ...
The Trentonian

Ortho’s VITROS(R) SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

RARITAN, N.J., March 23, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received authorization ...